肝硬化患者30天再入院大多不可预防
该前瞻性队列研究纳入2014年6月至2020年3月单中心住院的654例肝硬化患者,随访出院后30天。246例(38%)再入院,其中29例(12%)为可预防性再入院;可预防性再入院与种族和族裔少数群体、非已婚状态及既往30天内住院独立相关。
要点
- 肝硬化患者再入院常见,但仅12%可预防。
- 可预防性再入院常与腹腔穿刺及时性、利尿剂调整监测和肝性脑病治疗相关。
- 种族和族裔少数群体、非已婚状态、既往30天内住院与可预防性再入院独立相关。
核心结论
- 肝硬化患者再入院常见,但大多数不可预防;可预防性再入院常与腹水和肝性脑病相关,并与种族和族裔少数群体、非已婚状态及既往住院相关。
研究设计与样本
- 前瞻性队列研究,纳入2014年6月至2020年3月单中心住院的654例肝硬化患者,随访出院后30天。
主要发现
- 654例中246例(38%)再入院,其中29例(12%)为可预防性再入院;22例死亡(包括2例可预防性再入院)。
- 再入院最常见原因为肝性脑病(22%)、消化道出血(13%)、急性肾损伤(13%)和腹水(6%),可预防与不可预防再入院原因相似。
- 与没有再入院患者相比,可预防性再入院独立与种族和族裔少数群体(OR 5.80;95% CI,1.96-17.13)、非已婚状态(OR 2.88;95% CI,1.18-7.05)和既往30天内住院(OR 3.45;95% CI,1.48-8.04)相关。
关键数值与推荐
- 可预防性再入院判定由3名评审独立系统裁定,评审对70%的再入院可预防性达成一致。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Hospital readmissions are common in patients with cirrhosis, but there are few studies describing readmission preventability. We aimed to describe the incidence, causes, and risk factors for preventable readmission in this population. METHODS: We performed a prospective cohort study of patients with cirrhosis hospitalized at a single center between June 2014 and March 2020 and followed up for 30 days postdischarge. Demographic, clinical, and socioeconomic data, functional status, and quality of life were collected. Readmission preventability was independently and systematically adjudicated by 3 reviewers. Multinomial logistic regression was used to compare those with (i) preventable readmission, (ii) nonpreventable readmission/death, and (iii) no readmission. RESULTS: Of 654 patients, 246 (38%) were readmitted, and 29 (12%) were preventable readmissions. Reviewers agreed on preventability for 70% of readmissions. Twenty-two (including 2 with preventable readmission) died. The most common reasons for readmission were hepatic encephalopathy (22%), gastrointestinal bleeding (13%), acute kidney injury (13%), and ascites (6%), and these reasons were similar between preventable and nonpreventable readmissions. Preventable readmission was often related to paracentesis timeliness, diuretic adjustment monitoring, and hepatic encephalopathy treatment. Compared with nonreadmitted patients, preventable readmission was independently associated with racial and ethnic minoritized individuals (odds ratio [OR] 5.80; 95% CI, 1.96-17.13), nonmarried marital status (OR 2.88; 95% CI, 1.18-7.05), and admission in the prior 30 days (OR 3.45; 95% CI, 1.48-8.04). DISCUSSION: For patients with cirrhosis, readmission is common, but most are not preventable. Preventable readmissions are often related to ascites and hepatic encephalopathy and are associated with racial and ethnic minorities, nonmarried status, and prior admissions.
引用
- Orman ES, Desai AP, Ghabril MS, et al. Thirty-Day Readmissions Are Largely Not Preventable in Patients With Cirrhosis. Am J Gastroenterol. 2023. PMID: 37543729. doi:10.14309/ajg.0000000000002455
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。